5:52 PM
 | 
Feb 05, 2013
 |  BC Extra  |  Politics & Policy

GSK to release all clinical trial reports

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) became the first pharma to publicly support the AllTrials campaign, which is calling for the disclosure of clinical trial results and clinical study reports to increase trial transparency. GSK, which in October committed to release anonymized patient-level data, said in a statement on Tuesday that it will also...

Read the full 241 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >